Data as of Aug 22
| +0.13 / +1.23%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 29.00 and a low estimate of 18.00. The median estimate represents a +77.40% increase from the last price of 10.71.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.